Jobless claims fall but markets open lower

First time applications for unemployment benefits fell more than expected but the markets opened lower with the Dow losing 36 points to 16,875. Nasdaq dropped 35 points to 4,755.

On the upside

WaferGen Bio-systems (Nasdaq: WGBS) expects to report record revenue for the third quarter and lifted its full year revenue guidance.

Gannett (NYSE: GCI) will pay a premium of approximately $280 million to acquire Journal Media Group (NYSE: JMG).

Icahn Enterprises’ tender offer of Vivus’ (Nasdaq: VVUS) convertible senior notes expired.

On the downside

Cardiovascular Systems (Nasdaq: CSII) warned of wider losses for the first quarter.

The U.S. Preventive Services Task Force identified Exact Sciences (Nasdaq: EXAS) Cologuard as an alternative screening test for colorectal cancer rather than a recommended test.

BioCryst Pharmaceuticals (Nasdaq: BCRX) reported that its Phase 1 clinical trial of orally administered BCX7353 met its objectives and that it completed enrollment in OPuS-2 but the stock price fell.

In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on the NYSE while decliners edged out advancers by nearly 5 to 4 on Nasdaq. The broader S&P 500 lost 6 points to 1,989. Bitcoin held steady at $242.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.